NCT06612320

Brief Summary

The main objective is to assess whether there are factors associated with women's refusal to participate in a randomized clinical trial involving pregnancy and childbirth in France. The secondary objective is to qualitatively evaluate the reasons for acceptance and refusal to participate.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
526

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

September 25, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

October 31, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 28, 2025

Completed
Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

12 months

First QC Date

September 6, 2024

Last Update Submit

April 2, 2026

Conditions

Keywords

Refusalclinical trialfactorsreasonspregnancypre-eclampsia

Outcome Measures

Primary Outcomes (3)

  • Collection of maternal demographic characteristics

    Age, level of education, profession, geographic origin, health insurance/mutual, marital status The primary objective is to assess whether there are factors associated with women's refusal to participate in randomized clinical trials. No score, it is a qualitative analyse.

    Day 1

  • Collection of obstetric characteristics

    Parity, obstetric history (first-trimester pregnancy loss, IUFD, perinatal death), pregnancy complications, gestational age… The primary objective is to assess whether there are factors associated with women's refusal to participate in randomized clinical trials. No score, it is a qualitative analyse.

    Day 1

  • Collection of characteristics related to information provided

    By whom? , with whom? (impact of the companion), when? The primary objective is to assess whether there are factors associated with women's refusal to participate in randomized clinical trials. No score, it is a qualitative analyse.

    Day 1

Secondary Outcomes (2)

  • Motivation linked to acceptance

    Day 1

  • Reason for refusing to participate

    Day 1

Study Arms (2)

Acceptance

Women who accept to participate to a Randomized Controlled Trial (RCT)

Behavioral: Questionnaire about acceptance

Refusal

Women who refuse to participate to a Randomized Controlled Trial (RCT)

Behavioral: Questionnaire about refusal

Interventions

Questionnaire about acceptance

Acceptance

Questionnaire about refusal

Refusal

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will be offered to all women who have been offered to participate in a randomized trial relating to their pregnancy and/or childbirth in participating services.

You may qualify if:

  • The study will be offered to all women who have been offered to participate in a randomized trial relating to their pregnancy and/or childbirth in participating services.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

APHP - Antoine Béclère hospital - Maternity

Clamart, IDF, 92140, France

Location

APHP - Louis Mourier hospital - Maternity

Colombes, IDF, 92700, France

Location

APHP - Trousseau Hospital - Gynecology-Obstetrics-Maternity

Paris, IDF, 75010, France

Location

APHP - Port-Royal Maternity

Paris, IDF, 75014, France

Location

MeSH Terms

Conditions

Treatment RefusalPre-Eclampsia

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehaviorHypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Yoann Athiel, MD

    Port-Royal Maternity - APHP

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2024

First Posted

September 25, 2024

Study Start

October 31, 2024

Primary Completion

October 28, 2025

Study Completion

October 28, 2025

Last Updated

April 8, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations